Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Losartan
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Losartan
Tree Number(s)
D02.455.426.559.389.185.475
D03.383.129.308.507
D03.383.129.617.467
Unique ID
D019808
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D019808
Scope Note
An antagonist of
ANGIOTENSIN TYPE 1 RECEPTOR
with antihypertensive activity due to the reduced pressor effect of
ANGIOTENSIN II
.
Entry Term(s)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
Cozaar
DuP-753
Losartan Monopotassium Salt
Losartan Potassium
MK-954
MK954
Pharm Action
Anti-Arrhythmia Agents
Antihypertensive Agents
Angiotensin II Type 1 Receptor Blockers
Related Numbers
114798-26-4
124750-99-8
3ST302B24A
Previous Indexing
Biphenyl Compounds (1990-1997)
Imidazoles (1990-1997)
Tetrazoles (1990-1997)
See Also
Valsartan
Public MeSH Note
98; LOSARTAN was indexed under IMIDAZOLES 1990-97, TETRAZOLES 1990-97, & BIPHENYL COMPOUNDS 1990-97
History Note
98; use LOSARTAN (NM) 1990-97
Date Established
1998/01/01
Date of Entry
1997/06/20
Revision Date
2016/05/31
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
agonists (AG)
analogs & derivatives (AA)
analysis (AN)
antagonists & inhibitors (AI)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Organic Chemicals [D02]
Hydrocarbons [D02.455]
Hydrocarbons, Cyclic [D02.455.426]
Hydrocarbons, Aromatic [D02.455.426.559]
Benzene Derivatives [D02.455.426.559.389]
Biphenyl Compounds [D02.455.426.559.389.185]
Aminobiphenyl Compounds [D02.455.426.559.389.185.060]
Benzidines [D02.455.426.559.389.185.100]
Clofenapate [D02.455.426.559.389.185.210]
Dianisidine [D02.455.426.559.389.185.220]
Flurbiprofen [D02.455.426.559.389.185.350]
Irbesartan [D02.455.426.559.389.185.413]
Losartan [D02.455.426.559.389.185.475]
Niclofolan [D02.455.426.559.389.185.600]
Polybrominated Biphenyls [D02.455.426.559.389.185.680]
Polychlorinated Biphenyls [D02.455.426.559.389.185.698]
Telmisartan [D02.455.426.559.389.185.849]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Azoles [D03.383.129]
Imidazoles [D03.383.129.308]
Aminoimidazole Carboxamide [D03.383.129.308.030]
Antazoline [D03.383.129.308.040]
Biotin [D03.383.129.308.080]
Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide [D03.383.129.308.090]
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone [D03.383.129.308.100]
Carbimazole [D03.383.129.308.108]
Cimetidine [D03.383.129.308.130]
Clotrimazole [D03.383.129.308.175]
Creatinine [D03.383.129.308.207]
Dacarbazine [D03.383.129.308.240]
Dexmedetomidine [D03.383.129.308.245]
Econazole [D03.383.129.308.250]
Enoximone [D03.383.129.308.253]
Etimizol [D03.383.129.308.260]
Etomidate [D03.383.129.308.265]
Fadrozole [D03.383.129.308.270]
Fluspirilene [D03.383.129.308.290]
Histamine [D03.383.129.308.373]
Histidinol [D03.383.129.308.385]
Idazoxan [D03.383.129.308.428]
Imidazolidines [D03.383.129.308.432]
Imidazolines [D03.383.129.308.436]
Impromidine [D03.383.129.308.445]
Levamisole [D03.383.129.308.480]
Losartan [D03.383.129.308.507]
Medetomidine [D03.383.129.308.521]
Methimazole [D03.383.129.308.535]
Miconazole [D03.383.129.308.550]
Naphazoline [D03.383.129.308.585]
Niridazole [D03.383.129.308.626]
Nitroimidazoles [D03.383.129.308.658]
Olmesartan Medoxomil [D03.383.129.308.674]
Ondansetron [D03.383.129.308.690]
Oxymetazoline [D03.383.129.308.704]
Phentolamine [D03.383.129.308.754]
Tetramisole [D03.383.129.308.884]
Trimethaphan [D03.383.129.308.935]
Urocanic Acid [D03.383.129.308.960]
Vardenafil Dihydrochloride [D03.383.129.308.980]
Zoledronic Acid [D03.383.129.308.990]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Azoles [D03.383.129]
Tetrazoles [D03.383.129.617]
Cefotetan [D03.383.129.617.235]
Cefozopran [D03.383.129.617.264]
Cilostazol [D03.383.129.617.293]
Irbesartan [D03.383.129.617.351]
Losartan [D03.383.129.617.467]
Olmesartan Medoxomil [D03.383.129.617.584]
Tetrazolium Salts [D03.383.129.617.700]
Valsartan [D03.383.129.617.850]
Expand All
Collapse All
Losartan
Preferred
Concept UI
M0029400
Related Numbers
114798-26-4
124750-99-8
3ST302B24A
Scope Note
An antagonist of
ANGIOTENSIN TYPE 1 RECEPTOR
with antihypertensive activity due to the reduced pressor effect of
ANGIOTENSIN II
.
Terms
Losartan
Preferred Term
Term UI
T058934
Date
01/01/1999
LexicalTag
NON
ThesaurusID
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
Term UI
T058935
Date
02/03/1997
LexicalTag
NON
ThesaurusID
NLM (1998)
DuP-753
Narrower
Concept UI
M0029401
Terms
DuP-753
Preferred Term
Term UI
T058936
Date
01/24/1997
LexicalTag
LAB
ThesaurusID
NLM (1998)
MK-954
Narrower
Concept UI
M0351837
Terms
MK-954
Preferred Term
Term UI
T058939
Date
01/24/1997
LexicalTag
LAB
ThesaurusID
NLM (1998)
MK954
Term UI
T058937
Date
01/24/1997
LexicalTag
LAB
ThesaurusID
NLM (1998)
Losartan Potassium
Narrower
Concept UI
M0351838
Terms
Losartan Potassium
Preferred Term
Term UI
T058938
Date
12/30/1996
LexicalTag
NON
ThesaurusID
Losartan Monopotassium Salt
Term UI
T359328
Date
09/13/1999
LexicalTag
NON
ThesaurusID
NLM (1999)
Cozaar
Narrower
Concept UI
M0457185
Terms
Cozaar
Preferred Term
Term UI
T562376
Date
12/09/2003
LexicalTag
TRD
ThesaurusID
NLM (2005)
page delivered in 0.164s